Lv3
288 积分 2024-05-22 加入
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
9天前
已完结
A review of bridging clinical studies between different presentations of biological products approved by the United States Food and Drug Administration (US FDA)
1个月前
已完结
A review of bridging clinical studies between different presentations of biological products approved by the United States Food and Drug Administration (US FDA)
1个月前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
1个月前
已完结
2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists
1个月前
已完结
Model‐based meta‐analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B‐infected mice
1个月前
已关闭
Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients with Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia
1个月前
已完结
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia
2个月前
已完结
Report of the European Medicines Agency Conference on RNA-Based Medicines
2个月前
已完结
Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies
2个月前
已完结
皖公网安备34019202002308
